You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

steroid-refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Steroid-refractory Diamond-Blackfan Anemia (DBA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Bitopertin)

Not yet recruiting
  • Steroid-refractory Diamond-Blackfan Anemia (DBA)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2023

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Ulcerative Colitis Trial (Tofacitinib, Cyclosporine)

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Sep 26, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 20, 2022

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

Recruiting
  • Chronic Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Acute-graft-versus-host Disease Trial (ASC930)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • ASC930
  • (no location specified)
Nov 16, 2021

Acute GVHD Trial in Zhengzhou (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Acute Graft-Versus-Host Disease
  • Jaktinib Hydrochloride Tablets
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Nov 29, 2021

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Chronic GVHD Trial in Boston (Abatacept)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France (MaaT013)

Available
  • Acute Graft Versus Host Disease in Intestine
  • Steroid Refractory GVHD
  • Amiens, France
  • +19 more
Jun 20, 2022

Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

Available
  • Steroid Resistant Acute Graft Versus Host Disease
  • inolimomab
  • Lyon, France
    ElsaLys Biotech
Sep 16, 2021

Ulcerative Colitis Trial in Portugal, Spain (Adacolumn)

Recruiting
  • Ulcerative Colitis
  • Adacolumn
  • Coimbra, Portugal
  • +9 more
Jun 22, 2022

Intestinal GVHD, Steroid Refractory GVHD Trial in France (Blood and stool sample collection)

Recruiting
  • Intestinal GVHD
  • Steroid Refractory GVHD
  • Blood and stool sample collection
  • Amiens, France
  • +8 more
Jun 20, 2022

Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

Recruiting
  • Chronic Graft vs Host Disease
  • Regulatory T-cell enriched infusion
  • Sevilla, Spain
    José Antonio Pérez Simón
May 20, 2022

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))

Not yet recruiting
  • Graft Versus Host Disease
  • Allogeneic mesenchymal stromal cells (MSCs)
  • Extracorporeal photopheresis (ECP)
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022